#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLfellows: Lois Riobo & Sílvia Plans

Advancing Early Diagnosis of PDAC through Epidemiology and DNA Methylation Analysis Lois Riobo Mayo Colorectal Cancer group…

Read More

Thesis: Molecular Determinants of Early-Onset Thyroid Lesions: the miRNA Biogenesis Pathway as a Main Player

Thesis defense: December 1st at 12:00, sala Pau Viladiu. Molecular Determinants of Early-Onset Thyroid Lesions: the miRNA…

Read More

Regulatoria en ATMPs

Este curso ofrece una visión completa del ámbito regulatorio aplicado a los medicamentos, con especial atención a…

Read More

#IDIBELLfellows: Blanca Rius & Irene Peñuelas

Integrative Metabolomic and Genomic Analysis Identifies the Polyamine Metabolite Acisoga as Candidate Metabolic Marker for Colorectal Neoplasia…

Read More

Salut mental amb enfoc Interprofessional (II Jornada)

Jornada gratuïta, adreçada a tots els professionals que treballen en l’àmbit de l’Atenció Primària i especialitzada en…

Read More

Thesis: Dissecting the interactions between leukemic cells and the ageing niche

Thesis defense: tuesday November 25, 15:00,  Sala de Graus UB Bellvitge. Thesis: Dissecting the interactions between leukemic…

Read More

Thesis: Modelling precancer in Mismatch Repair Deficiency syndromes as a potential strategy for precision surveillance and prevention

Thesis defense: wednesday December 3, 15:00, Sala de Actes Pau Viladiu (Hospital Duran i Reynals) Modelling precancer…

Read More

#IDIBELLseminars: Tumor Microenvironment–Driven Heterogeneity in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive form of cancer, with a 5-year survival rate of…

Read More

IMARIS WORKSHOP: A Revolution in Image Analysis

IDIBELL is taking image analysis to the next level with the acquisition of the latest version of Imaris…

Read More

Artificial Intelligence at the Threshold of Cancer Epidemiology, Pathology, and Outcomes

Hosted by: Gabriel Capellá, Laura Valle – Hereditary cancer group Victor Moreno – Colorectal cancer group  …

Read More
Desplaça cap amunt